The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue 3, 2001, Pages 199-203

  Tran, Diane ^a   Phoon, Stephen ^a   Howes, Laurence ^a,b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Angiotensin II; Candesartan cilexetil; Norepinephrine; Vascular responsiveness

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; CANDESARTAN; NORADRENALIN; TETRAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOREARM; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; TIME; VASCULARIZATION;

ADULT; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE; BLOOD VESSELS; BRACHIAL ARTERY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOREARM; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; NOREPINEPHRINE; REFERENCE VALUES; REGIONAL BLOOD FLOW; TETRAZOLES; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 0035468919     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2001.028     Document Type: Article

References (8)

1. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WE. Non-peptide angiotensin II receptor antagonists. TIPS 1991;12:55-62.
2. 2 receptors. Blood Pressure 1996;5(suppl 2):47-52.
3. Mancia G, Dell'Ovo R, Turn C, Grassi G. Comparison of angiotensin II receptor blockers: impact of missed doses of candesartan cilexetil and losartan in systemic hypertension. Am J Cardiol 1999;84(10A):28S-34S.
4. Zuschke CA, Keys I, Munger MA et al. Candesartan cilexetil: comparison of once daily versus twice daily administration for systemic hypertension. Clin Ther 1999;21(3):464-74.
5. Delacretaz E, Nussberger J, Biollaz J, Waeber B, Brunner HR. Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. Hypertension 1995;25:14-21.
6. Belz CG, Fuchs B, Malerczyk C, Magin SG, Roll S, Mutschler E. Inhibition of angiotensin II pressor response and ex vivo angiotensin II radioligand binding by candesartan cilexetil and losartan in healthy human volunteers. J Hum Hypertens 1997;11(suppl 2):S45-S47.
7. Ruiz-Gayo M, Somoza B, Fernandez-Alfonso MS, Gonzalez C. Chronic losartan treatment decreases angiotensin II facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats. Life Sci 2000;67(26):3153-62.
8. Harada K, Kawaguchi A, Ohmori M, Fujimura A. Influence of losartan on alpha-adrenoreceptor mediated vasoconstrictor responses in humans. J Cardiovasc Pharmacol 2000;36(1):45-9.